PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsYoichi Nagata, Dihua Yu, Keng‐Hsueh Lan et al.|Cancer Cell|2004Cited by 1.9k
The 2019 World Health Organization classification of tumours of the breastPuay Hoon Tan, Roberto Salgado, Anna Sapino et al.|Histopathology|2020Cited by 1.1k
Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancersRuiying Zhao, Mong-Hong Lee, Sai‐Ching J. Yeung et al.|Journal of Clinical Investigation|2011Cited by 106
Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiencyRachel L. Atkinson, Jenny C. Chang, Wei Yang et al.|Breast Cancer Research|2013Cited by 71
Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast CancerMohamed A. Gouda, Funda Meric‐Bernstam, Amrit S. Gonugunta et al.|Clinical Cancer Research|2025Cited by 13